International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections

Ghufran Mohammed Sadee Merie, Hadeel Tahseen Al-hashimi, Ali M Saadi

Department of Medical Laboratory Technologies, Mosul Medical Technical Institute, Northern Technical University, Iraq; Department of Medicinal Plant Technologies, Technical Agricultural College, Northern Technical University, Iraq

Article Information

Volume / Issue6 / 1 (January-March 2025)
Pages29-37
AccessOpen Access

Publication Timeline

  • Received11 November 2024
  • Accepted15 December 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

It is possible that the abstract of the paper "Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections" encapsulates the main conclusions and revelations about the function of cytokine storms in relation to bacterial infections. It could go over the processes that cause cytokine storms, how they affect the host's immune system, and possible treatment targets that could lessen the negative consequences of these storms. A succinct description of cytokine storms and their significance in bacterial infections. A succinct description of cytokine storms and their significance in bacterial infections. Talk about possible tactics and remedies for controlling or averting cytokine storms. a synopsis of how these findings may affect clinical practice and future study.

Keywords

Cytokine StormsTherapeutic TargetsAcute Respiratory Distress Syndrome (ARDS)Pro-inflammatory Cytokines

References

  1. Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, et al. Pathogenesis and treatment of cytokine storm induced by infectious diseases. International Journal of Molecular Sciences. 2021;22(23):13009. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  2. Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, et al. Role of inflammatory cytokines in COVID-19 patients: A review on molecular International Journal of Medical and All Body Health Research www.allmedicaljournal.com mechanisms, immune functions, immunopathology, and immunomodulatory drugs to counter cytokine storm. Vaccines. 2021;9(5):436. Available from: mdpi.com. [Google Scholar][Crossref]
  3. Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, et al. Autoinflammatory diseases and cytokine storms—imbalances of innate and adaptative immunity. International Journal of Molecular Sciences. 2021;22(20):11241. Available from: mdpi.com. [Google Scholar][Crossref]
  4. Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, et al. Pathogenesis and treatment of cytokine storm induced by infectious diseases. International Journal of Molecular Sciences. 2021;22(23):13009. Available from: mdpi.com. [Google Scholar][Crossref]
  5. Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, et al. Immunopathogenesis and treatment of cytokine storm in COVID -19. Theranostics. 2021;11(1):316. Available from: nih.gov. [Google Scholar][Crossref]
  6. Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clinical Microbiology Reviews. 2021. Available from: asm.org. [Google Scholar][Crossref]
  7. Karki R, Kanneganti TD. The 'cytokine storm': molecular mechanisms and therapeutic prospects. Trends in Immunology. 2021. Available from: cell.com. [Google Scholar][Crossref]
  8. Reddy H, Kumar Javvaji C, Malali S, Kumar S, Acharya S, Toshniwal S. Navigating the cytokine storm: A comprehensive review of chemokines and cytokines in sepsis. International Journal of Molecular Sciences. 2024. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  9. Jiang Y, Rubin L, Peng T, Liu L, Xing X, Lazarovici P, et al. Cytokine storm in COVID-19: From viral infection to immune responses, diagnosis, and therapy. International Journal of Biological Sciences. 2022;18(2):459. Available from: nih.gov. [Google Scholar][Crossref]
  10. Jarczak D, Nierhaus A. Cytokine storm—definition, causes, and implications. International Journal of Molecular Sciences. 2022. Available from: mdpi.com. [Google Scholar][Crossref]
  11. Hu B, Huang S, Yin L. The cytokine storm and COVID‐ 19. Journal of Medical Virology. 2021. Available from: nih.gov. [Google Scholar][Crossref]
  12. Valdes-Aguayo JJ, Garza-Veloz I, Badillo-Almaraz JI, Bernal-Silva S, Martinez-Vazquez MC, Juarez-Alcala V, et al. Mitochondria and mitochondrial DNA: Key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Medicina. 2021;57(9):928. Available from: mdpi.com. [Google Scholar][Crossref]
  13. Rihar E, Peršič V, Jerman A, Plankar Srovin T, Mlakar G, Bezeljak N, et al. Hemoperfusion with CytoSorb® in pediatric patients: A monocentric case series. Journal of Clinical Medicine. 2024;13(21):6587. Available from: mdpi.com. [Google Scholar][Crossref]
  14. Müller L, Di Benedetto S. How immunosenescence and inflammaging may contribute to hyperinflammatory syndrome in COVID-19. International Journal of Molecular Sciences. 2021. Available from: mdpi.com. [Google Scholar][Crossref]
  15. Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges. Scandinavian Journal of Immunology. 2022;95(2):e13131. Available from: wiley.com. [Google Scholar][Crossref]
  16. Greenfield KG, Badovinac VP, Griffith TS, Knoop KA. Sepsis, cytokine storms, and immunopathology: The divide between neonates and adults. ImmunoHorizons. 2021;5(6):512-522. Available from: aai.org. [Google Scholar][Crossref]
  17. Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, et al. The mechanism behind influenza virus cytokine storm. Viruses. 2021;13(7):1362. Available from: mdpi.com. [Google Scholar][Crossref]
  18. Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, et al. Diverse immunological factors influencing pathogenesis in patients with COVID-19: A review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens. 2021;10(5):565. Available from: mdpi.com. [Google Scholar][Crossref]
  19. Ahmad R, Haque M. Surviving the storm: Cytokine biosignature in SARS-CoV-2 severity prediction. Vaccines. 2022. Available from: mdpi.com. [Google Scholar][Crossref]
  20. Yousif SO. Relation of hypercytokinemia (cytokine storm) in viral respiratory SARS-COVID-2. IIARD Journals. Available from: iiardjournals.org. [Google Scholar][Crossref]
  21. Bhadoria P, Rathore H. Multi-organ system dysfunction in Covid-19—a review. Journal of Evolution of Medical and Dental Sciences. 2021. Available from: researchgate.net. [Google Scholar][Crossref]
  22. Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Annals of the Rheumatic Diseases. 2021;80(1):88-95. Available from: bmj.com. [Google Scholar][Crossref]
  23. Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, et al. When does the cytokine storm begin in COVID-19 patients? A quick score to recognize it. Journal of Clinical Medicine. 2021;10(2):297. Available from: mdpi.com. [Google Scholar][Crossref]
  24. van Heerden PV, Abutbul A, Sviri S, Zlotnick E, Nama A, Zimro S, et al. Apoptotic cells for therapeutic use in cytokine storm associated with sepsis—a phase Ib clinical trial. Frontiers in Immunology. 2021;12:718191. Available from: frontiersin.org. [Google Scholar][Crossref]
  25. O'Reilly D, McGrath J, Martin-Loeches I. Optimizing artificial intelligence in sepsis management: Opportunities in the present and looking closely to the future. Journal of Intensive Medicine. 2024. Available from: sciencedirect.com. [Google Scholar][Crossref]
  26. Hussain S, Mubeen I, Ullah N, Shah SSUD, Khan BA, Zahoor M, et al. Modern diagnostic imaging technique applications and risk factors in the medical field: A review. BioMed Research International. 2022;2022(1):5164970. Available from: wiley.com. [Google Scholar][Crossref]
  27. Pascoal E, Wessels JM, Aas‐Eng MK, Abrao MS, Condous G, Jurkovic D, et al. Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy research. Ultrasound in Obstetrics & Gynecology. 2022;60(3):309-27. Available from: wiley.com. [Google Scholar][Crossref]
  28. Liu G, Jiang C, Lin X, Yang Y. Point‐of‐care detection of cytokines in cytokine storm management and beyond: Significance and challenges. View. 2021. Available from: wiley.com. [Google Scholar][Crossref]
  29. Mohammed MA. Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now. Frontiers in Pharmacology. 2023. Available from: frontiersin.org. [Google Scholar][Crossref]
  30. Li R, Ye JJ, Gan L, Zhang M, Sun D, Li Y, et al. Traumatic inflammatory response: Pathophysiological role and clinical value of cytokines. European Journal of Trauma and Emergency Surgery. 2024;50(4):1313-30. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Available from: springer.com. [Google Scholar][Crossref]
  31. David P, Hansen FJ, Bhat A, Weber GF. An overview of proteomic methods for the study of ‘cytokine storms’. Expert Review of Proteomics. 2021;18(2):83-91. Available from: researchgate.net. [Google Scholar][Crossref]
  32. de la Rica R, Borges M, Gonzalez-Freire M. COVID-19: In the eye of the cytokine storm. Frontiers in Immunology. 2020. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  33. Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, et al. The looming storm: Blood and cytokines in COVID -19. Blood Reviews. 2021;46:100743. Available from: nih.gov. [Google Scholar][Crossref]
  34. Stolarski AE, Kim J, Zhang Q, Remick DG. Cytokine drizzle—the rationale for abandoning “cytokine storm”. Shock. 2021. Available from: researchgate.net. [Google Scholar][Crossref]
  35. Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Frontiers in Immunology. 2021. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  36. Hann Ng W, Chun Hean Tang P, Mahalingam S, Liu X. Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2. Frontiers in Pharmacology. 2023. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  37. Clark IA. Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm. Reviews in Medical Virology. 2021. Available from: wiley.com. [Google Scholar][Crossref]
  38. Basheer M, Saad E, Assy N. The cytokine storm in COVID-19: The strongest link to morbidity and mortality in the current epidemic. COVID. 2022. Available from: mdpi.com. [Google Scholar][Crossref]
  39. Chan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, et al. The roles of neutrophils in cytokine storms. Viruses. 2021;13(11):2318. Available from: mdpi.com. [Google Scholar][Crossref]
  40. Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. Quantification of cytokine storms during virus infections. Frontiers in Immunology. 2021;12:659419. Available from: frontiersin.org. [Google Scholar][Crossref]
  41. Taya T, Teruyama F, Gojo S. Host-directed therapy for bacterial infections—Modulation of the phagolysosome pathway. Frontiers in Immunology. 2023. Available from: ncbi.nlm.nih.gov. [Google Scholar][Crossref]
  42. Wallis RS, O'Garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: Past, present and future. Nature Reviews Immunology. 2023. Available from: nature.com. [Google Scholar][Crossref]
  43. McCarty SM, Clasby MC, Sexton JZ. High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration. ASSAY and Drug Development Technologies. 2024;22(3):148-159. Available from: umich.edu. [Google Scholar][Crossref]
  44. Ma Q, Tong H, Jing J. High throughput virtual screening strategy to develop a potential treatment for bronchial asthma by targeting interleukin 13 cytokine signaling. Allergologia et Immunopathologia. 2022. Available from: all-imm.com. [Google Scholar][Crossref]
  45. Zhang Y, Xu Q, Gao Z, Zhang H, Xie X, Li M. High-throughput screening for optimizing adoptive T cell therapies. Experimental Hematology & Oncology. 2024;13(1):113. Available from: springer.com. [Google Scholar][Crossref]
  46. Zhang K, Tang Y, Chen Q, Liu Y. The screening of therapeutic peptides for anti-inflammation through phage display technology. International Journal of Molecular Sciences. 2022;23(15):8554. Available from: mdpi.com. [Google Scholar][Crossref]
  47. Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced Drug Delivery Reviews. 2021. Available from: nih.gov. [Google Scholar][Crossref]
  48. Sharun K, Tiwari R, Yatoo MI, Natesan S, Megawati D, Singh KP, et al. A comprehensive review on pharmacologic agents, immunotherapies, and supportive therapeutics for COVID-19. Narra Journal. 2022;2(3). Available from: nih.gov. [Google Scholar][Crossref]
  49. Baker DJ, Arany Z, Baur JA, Epstein JA, June CH. CAR T therapy beyond cancer: The evolution of a living drug. Nature. 2023. Available from: upenn.edu. [Google Scholar][Crossref]
  50. Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S, et al. The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomedicine & Pharmacotherapy. 2024;178:117177. Available from: sciencedirect.com. [Google Scholar][Crossref]
  51. Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS. Lessons learned: New insights on the role of cytokines in COVID-19. Nature Immunology. 2021;22(4):404-411. Available from: nature.com. [Google Scholar][Crossref]

How to Cite

Merie, G. M. S., Al-hashimi, H. T., & Saadi, A. M. (2025). Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections. International Journal of Medical and All Body Health Research, 6(1), 29-37. https://doi.org/10.54660/IJMBHR.2025.6.1.29-37

Merie, Ghufran Mohammed Sadee, et al. "Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections." International Journal of Medical and All Body Health Research, vol. 6, no. 1, 2025, pp. 29-37. https://doi.org/10.54660/IJMBHR.2025.6.1.29-37.

Merie, G. M. S., Al-hashimi, H. T. and Saadi, A. M. (2025) 'Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections', International Journal of Medical and All Body Health Research, 6(1), pp. 29-37. doi: 10.54660/IJMBHR.2025.6.1.29-37.

Merie GMS, Al-hashimi HT, Saadi AM. Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections. International Journal of Medical and All Body Health Research. 2025;6(1):29-37. doi:10.54660/IJMBHR.2025.6.1.29-37

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.